Curt LaBelle

Curt LaBelle

Presidente presso
Global Health Investment Fund
55 anni
Health Technology
Finance
Health Services

Profilo

Curt H.
LaBelle
is currently Chairman-Steering Committee at Serum Institute of India Pvt Ltd. since 2017.
Director at Vedanta Biosciences, Inc. since 2023.
Director at KeepYourSight Foundation, Ophirex, Inc., Revelation Biosciences Sub, Inc. since 2021, CXL Ophthalmics LLC since 2022, Atticus Medical Pty Ltd. since 2015, IanTech, Inc. since 2015, and Adjuvant Capital LP.
Venture Partner.
President & Managing Partner at Global Health Investment Fund since 2015.
Board Member at Maternal Newborn Health Innovations PBC since 2022.
Managing Partner at AXA IM Alts since 2022.
Former roles include Chairman at NuVasive Clinical Services Monitoring, Inc. (2008–2011), SafeOp Surgical, Inc. (2011–2015), Exagen, Inc. (2009–2015), and Alydia Health, Inc. (2018–2021).
Director at KAI Pharmaceuticals, Inc. (2006–2012), Sirion Therapeutics, Inc. (2006–2008), Atomo Diagnostics Ltd. (2016–2023), Hyperion DeFi, Inc. (2015–2022), and Revelation Biosciences, Inc. (2021–2023).
Partner & Managing Director at Tullis Health Investors, Inc. (2010–2015).
Managing Director at Global Health Investment Advisors LLC (2008–2015).
Vice President at Investor Growth Capital LLC (2005–2008) and Patricia Industries AB (2005–2007).
Senior Associate at Tullis Health Investors, Inc. (2002–2005).
Director at Vidacare Corp., Coherex Medical, Inc., Endoscopic Technologies, Inc., TransMolecular, Inc.Education includes a doctorate and an MBA from The Trustees of Columbia University in The City of New York and Columbia Business School, both conferred in 1999, and an undergraduate degree from Brigham Young University in 1994.

Posizioni attive di Curt LaBelle

SocietàPosizioneInizio
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio 01/01/2021
Investitore di Private Equity -
Atticus Medical Pty Ltd.
Direttore/Membro del Consiglio 01/09/2015
Direttore/Membro del Consiglio -
Investitore di Private Equity 01/06/2015
Investitore di Private Equity 01/06/2017
Direttore/Membro del Consiglio 01/07/2022
Direttore/Membro del Consiglio 01/10/2022
░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░

Precedenti posizioni note di Curt LaBelle

SocietàPosizioneFine
░░░░░ ░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Curt LaBelle

Formazione di Curt LaBelle

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

95

Relazioni di 1° grado

31

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private31

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Investor Growth Capital LLC

Consumer Services

Finance

Health Technology

Consumer Services

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Miscellaneous

Finance

Consumer Services

Finance

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Finance

Health Technology

Health Services

Health Technology

Atticus Medical Pty Ltd.

Health Services

  1. Mercati
  2. Insiders
  3. Curt LaBelle
-40% : Prolongation exceptionnelle ➤➤➤➤
g
:
:
ENTRA ORA